TikoMed’s ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro
Intellasia,
13-Sep-2022 Intellasia | PR Newswire Asia | 3:08 PM Adds further support for its broad-spectrum mechanism of action following…